跳转至内容
Merck
CN
所有图片(1)

文件

528100

Sigma-Aldrich

PI-103

A cell-permeable pyridinylfuranopyrimidine compound that acts as a potent and ATP-competitive inhibitor of DNA-PK, PI3-K, and mTOR.

登录查看公司和协议定价

别名:
PI-103, 3-(4-(4-吗啉基)吡啶并[3ʹ,2ʹ:4,5]呋喃并[3,2-d]嘧啶-2-基)苯酚,mTOR抑制剂V,PI 3-K抑制剂V
经验公式(希尔记法):
C19H16N4O3
分子量:
348.36
UNSPSC代码:
12352200
NACRES:
NA.77

质量水平

检测方案

≥97% (HPLC)

形式

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

white

溶解性

DMSO: 5 mg/mL

运输

ambient

储存温度

−20°C

InChI

1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2

InChI key

TUVCWJQQGGETHL-UHFFFAOYSA-N

一般描述

一种可渗透细胞的吡啶基呋喃嘧啶化合物,可作为DNA-PK,PI3-K和mTOR的强效和ATP竞争性抑制剂(DNA-PK,p110α,p110β,p110δ,p110γ,PI3-KC2β,mTORC1和mTORC2的IC50分别为2、8、88、48、150、26、20和83 nM)。 它仅在更高的浓度(分别为IC50=850和920 nM)下抑制ATR和ATM,并且即使在浓度高为10 µM时,对一组40多种其他激酶也几乎没有活性。已证明可有效阻断体外体内胶质瘤细胞系中的PI3-K/Akt信号传导和细胞增殖。也可购买10 mM(2 mg/574 µl)PI-103 DMSO溶液(目录号528101)。

生化/生理作用

主要靶标
DNA-PK,PI3-K和mTOR
产物与ATP竞争。
可逆:否
细胞可渗透性:具有
靶标IC50:DNA-PK,p110α,p110β,p110delta;,p110γ,PI3-KC2β,mTORC1和mTORC2分别为2、8、88、48、150、26、20和83 nM

包装

用惰性气体包装

警告

毒性:标准处理(A)

制备说明

完全溶解可能需要轻微加热。

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Qi-Wen Fan et al.
Cancer cell, 9(5), 341-349 (2006-05-16)
The PI3 kinase family of lipid kinases promotes cell growth and survival by generating the second messenger phosphatidylinositol-3,4,5-trisphosphate. To define targets critical for cancers driven by activation of PI3 kinase, we screened a panel of potent and structurally diverse drug-like
Florence I Raynaud et al.
Cancer research, 67(12), 5840-5850 (2007-06-19)
Extensive evidence implicates activation of the lipid phosphatidylinositide 3-kinase (PI3K) pathway in the genesis and progression of various human cancers. PI3K inhibitors thus have considerable potential as molecular cancer therapeutics. Here, we detail the pharmacologic properties of a prototype of
Zachary A Knight et al.
Cell, 125(4), 733-747 (2006-05-02)
Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined. We describe here an approach to pharmacologically interrogate the PI3-K family. A chemically diverse panel of PI3-K inhibitors was
PtdIns(3,4)P2, Lamellipodin, and VASP coordinate actin dynamics during phagocytosis in macrophages.
Monta??o-Rend??n, et al.
The Journal of cell biology, 221 (2023)
Evelina Valionyte et al.
Cell death and differentiation, 29(6), 1211-1227 (2021-12-05)
SQSTM1/p62, as a major autophagy receptor, forms droplets that are critical for cargo recognition, nucleation, and clearance. p62 droplets also function as liquid assembly platforms to allow the formation of autophagosomes at their surfaces. It is unknown how p62-droplet formation

商品

AldeRed™ 588-A detects ALDH activity in cancer stem cells, aiding in cancer research.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门